Australian API Manufacturer Hit for Quality Failures, Non-Conformance

Drug Industry Daily
A A
The FDA issued a Form 483 to active pharmaceutical ingredient manufacturer IDT Australia citing quality shortcomings and other deviations observed during a December inspection of its Boronia, Victoria, facility.

To View This Article:

Login

Subscribe To Drug Industry Daily